Cargando…

Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’

INTRODUCTION: The distinct properties of the centrally-acting analgesic tapentadol derive from the combined contributions of an opioid component and a nonopioid component. However, the opioid component’s relative contribution to analgesic and adverse effects has not previously been elucidated. Tapen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raffa, Robert B., Elling, Christian, Tzschentke, Thomas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182641/ https://www.ncbi.nlm.nih.gov/pubmed/30206823 http://dx.doi.org/10.1007/s12325-018-0778-x

Ejemplares similares

Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic
por: Stollenwerk, Ariane, et al.
Publicado: (2017)

Tapentadol hydrochloride: A novel analgesic
por: Singh, Dewan Roshan, et al.
Publicado: (2013)

Outcomes of the Pediatric Development Plan of Tapentadol
por: Eerdekens, Mariëlle, et al.
Publicado: (2021)

Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old
por: Khalil, Feras, et al.
Publicado: (2020)

Ten Years of Strong Opioid Analgesics Consumption in Malaysia and Other Southeast Asian Countries
por: Zin, Che Suraya
Publicado: (2020)

Finishing Strong
por: Fonseca, Vivian A.
Publicado: (2011)

Strong Heart, Low Ceramides
por: Holland, William L., et al.
Publicado: (2018)

The influence of μ-opioid and noradrenaline reuptake inhibition in the modulation of pain responsive neurones in the central amygdala by tapentadol in rats with neuropathy
por: Gonçalves, Leonor, et al.
Publicado: (2015)

Role of preemptive tapentadol in reduction of postoperative analgesic requirements after laparoscopic cholecystectomy
por: Yadav, Ghanshyam, et al.
Publicado: (2016)

Analgesic Efficacy and Safety of Tapentadol Immediate Release in Bunionectomy: A Meta-Analysis
por: Franco-de la Torre, Lorenzo, et al.
Publicado: (2023)

Boston Strong: The Role of Community Resilience
por: Ferrer, Barbara, et al.
Publicado: (2015)

Why make a strong muscle weaker?
por: Iorga, Bogdan, et al.
Publicado: (2021)

Tapentadol shows lower intrinsic efficacy at µ receptor than morphine and oxycodone
por: Manandhar, Preeti, et al.
Publicado: (2022)

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2018)

A comparative clinical evaluation of analgesic efficacy of Tapentadol and ketorolac in mandibular third molar surgery
por: Shah, Dixit, et al.
Publicado: (2017)

Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly—A Subgroup Analysis of Routine Clinical Practice Data
por: Schwittay, Andreas, et al.
Publicado: (2020)

The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism
por: Coluzzi, Flaminia, et al.
Publicado: (2015)

A Strong Case for Viral Genetic Factors in HIV Virulence
por: Müller, Viktor, et al.
Publicado: (2011)

Hopelessness during acute hospitalisation is a strong predictor of mortality
por: Gruber, Rita, et al.
Publicado: (2021)

Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
por: Vidal-Torres, Alba, et al.
Publicado: (2023)

Strong convergence of an extragradient-type algorithm for the multiple-sets split equality problem
por: Zhao, Ying, et al.
Publicado: (2017)

Strong ion difference in urine: new perspectives in acid-base assessment
por: Gattinoni, Luciano, et al.
Publicado: (2006)

mSphere of Influence: the Power of Yeast Genetics Still Going Strong!
por: Santiago-Tirado, Felipe H.
Publicado: (2019)

A Strong Public Health System: Essential for Health and Economic Progress
por: Frieden, Tom
Publicado: (2020)

Comparison of the Risks of Shopping Behavior and Opioid Abuse Between Tapentadol and Oxycodone and Association of Shopping Behavior and Opioid Abuse
por: Cepeda, M. Soledad, et al.
Publicado: (2014)

Electroweak and Strong Interactions: Phenomenology, Concepts, Models
por: Scheck, Florian
Publicado: (2012)

Commentary: One plus one does not always equal two: Mitochondrial cardioprotection
por: Guariento, Alvise, et al.
Publicado: (2021)

Weakly acidic, but strongly irritating: TRPA1 and the activation of nociceptors by cytoplasmic acidification
por: Garrity, Paul A.
Publicado: (2011)

Making the case for strong health information systems during a pandemic and beyond
por: Schmidt, Andrea E., et al.
Publicado: (2021)

To DNA, all information is equal
por: Sennels, Lau, et al.
Publicado: (2012)

Control of strong beam loading: Results with beam
por: Baudrenghien, P
Publicado: (2001)

Tapentadol: an overview of the safety profile
por: Polati, Enrico, et al.
Publicado: (2019)

Changes in trends and pattern of strong opioid prescribing in primary care
por: Zin, CS, et al.
Publicado: (2014)

Strong interactions of strong particles
por: Snow, G A
Publicado: (1962)

A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptor
por: Dekan, Zoltan, et al.
Publicado: (2019)

Strong Circadian Rhythms in the Choroid Plexus: Implications for Sleep-Independent Brain Metabolite Clearance
por: Myung, Jihwan, et al.
Publicado: (2018)

Can a Public Health Department Perform Well Without a Strong Workforce?
por: Bender, Kaye
Publicado: (2019)

TB research requires strong protections, innovation, and increased funding in response to COVID-19
por: Nyang’wa, B. T., et al.
Publicado: (2021)

“Classical cytogenetics” is not equal to “banding cytogenetics”
por: Liehr, Thomas
Publicado: (2017)

Parallel Strong-Strong/Strong-Weak Simulations of Beam-Beam Interaction in Hadron Accelerators
por: Qiang, Ji, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_7bbusj3rr6b8ecg7ct0d41qt3n